Gilead’s remdesivir could see $7 billion in annual sales on stockpiling boost: analyst

Gilead Sciences Inc’s (GILD.O) potential COVID-19 treatment, remdesivir, could bring in more than $7 billion in annual sales by 2022, spurred by governments stockpiling the drug to guard against future outbreaks, SVB Leerink said on Wednesday. Remdesivir has shown improvement in COVID-19 patients in clinical trials and has been cleared for emergency use in severely […]

Continue Reading

YouTube says China-linked comment deletions weren’t caused by outside parties

YouTube sparked widespread speculation about its moderation policies this week after it admitted to accidentally deleting comments that contained phrases critical of the Chinese Communist Party (CCP). Today, the company said that the issue was not the result of outside interference — an explanation for the error floated by many. The phrases that triggered automatic […]

Continue Reading